Carl Zeiss Meditec AG (ADR)

General ticker "CZMWY" information:

  • Sector: Health Care
  • Industry: Medical - Instruments & Supplies
  • Capitalization: $5.1B (TTM average)

Carl Zeiss Meditec AG (ADR) does not follow the US Stock Market performance with the rate: -10.1%.

Estimated limits based on current volatility of 2.2%: low 47.36$, high 49.52$

Factors to consider:

  • Company pays dividends (annually): last record date 2025-03-28, amount 0.65$ (Y1.38%)
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-09-30 to 2026-09-30

  • 2024-09-30 to 2025-09-30 estimated range: [48.46$, 89.72$]
  • 2025-09-30 to 2026-09-30 estimated range: [50.34$, 91.14$]

Financial Metrics affecting the CZMWY estimates:

  • Negative: with PPE of 32.0 at the end of fiscal year the price was very high
  • Positive: -3.60 < Operating profit margin, % of 5.87
  • Positive: 41.86 < Shareholder equity ratio, % of 60.17 <= 63.39
  • Negative: Operating cash flow per share per price, % of 4.46 <= 6.82
  • Positive: Industry inventory ratio change (median), % of 0.28 <= 0.28
  • Negative: 0 < Inventory ratio change, % of 0.69
  • Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.04
  • Positive: -14.38 < Investing cash flow per share per price, % of -7.44
  • Positive: Interest expense per share per price, % of 0.58 <= 0.79

Similar symbols

Short-term CZMWY quotes

Long-term CZMWY plot with estimates

Financial data

YTD 2023-09-30 2024-09-30
Operating Revenue €2,089.30MM €2,066.13MM
Operating Expenses €1,762.16MM €1,944.78MM
Operating Income €327.14MM €121.35MM
Non-Operating Income €85.43MM €119.52MM
Interest Expense €1.92MM €31.89MM
R&D Expense €349.28MM €343.09MM
Income(Loss) €412.56MM €240.87MM
Taxes €120.56MM €60.71MM
Profit(Loss)* €290.40MM €178.73MM
Stockholders Equity €2,159.45MM €2,041.70MM
Inventory €519.62MM €536.16MM
Assets €3,032.92MM €3,393.20MM
Operating Cash Flow €250.86MM €247.32MM
Capital expenditure €113.86MM €152.20MM
Investing Cash Flow €-110.98MM €-412.31MM
Financing Cash Flow €-135.09MM €176.25MM
Earnings Per Share** €3.25 €2.01
Ordinary share to ADR 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.